Thursday, 29 August 2019

AstraZeneca lupus drug meets main goal in study

AstraZeneca Plc said on Thursday its experimental drug to treat moderate-to-severe lupus, anifrolumab, met its main goal in a late-stage study.


from Reuters: Health News https://ift.tt/2ZsGnII

No comments:

Post a Comment